Comparison to Other Technologies
Independently from manufacturers’ specifications, Chimera Biotec tested different commercial kits and reagents. Based on in-house available technologies, we compared the advantages and limitations of common immunoassay platforms.
The comparison was done for the detection of TNFα in standardized human serum samples and the results are shown below.
- work still in progress-
The following table summarizes the results*:
